Medtronic (MDT) Net Cash Flow Growth (3y) (2017 - 2026)
Medtronic (MDT) Net Cash Flow Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 269.22% |
| 10 | Zimmer Biomet Holdings | 19.34 Bn | 18.93 Bn | 1.54 Bn | -45.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 31.32% |
| Jan 23, 2026 | 42.74% |
| Oct 24, 2025 | -74.18% |
| Jul 25, 2025 | 11.34% |
| Apr 25, 2025 | 22.40% |
| Jan 24, 2025 | -26.81% |
| Oct 25, 2024 | 41.47% |
| Jul 26, 2024 | 80.59% |
| Apr 26, 2024 | 42.54% |
| Jan 26, 2024 | 29.84% |
| Oct 27, 2023 | 46.71% |
| Jul 28, 2023 | -27.52% |
| Apr 28, 2023 | -97.92% |
| Jan 27, 2023 | -46.93% |
| Oct 28, 2022 | 65.82% |
| Jul 29, 2022 | -60.31% |
| Apr 29, 2022 | -18.42% |
| Jan 28, 2022 | 68.28% |
| Oct 29, 2021 | 40.28% |
| Jul 30, 2021 | -39.39% |